That actually is a very complex question. I think there's no doubt that we have learned from this supply shortage that the business model we have used in nuclear medicine is perhaps imperfect. I think that if we try to look at the tests that can be utilized as alternatives, there are some PET tests. Thallium is an effective test for cardiac imaging in perhaps 50% or 60% of patients. There is a PET cardiac test that we need to look at going into the future. Clearly, there has been some shift to non-nuclear-medicine-based testing as well. So I think that as this goes forward there will be a complete re-evaluation of the way in which we offer nuclear medicine services.
On August 21st, 2009. See this statement in context.